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Abstract 
The antibiotic, gentamicin sulphate (GS), was incorporated in gravity-spun polycaprolactone 
(PCL) fibers by spinning from particulate suspensions of the drug in PCL solution to produce a 
controlled delivery system. The production rate of GS-loaded PCL fibers was confined to the 
range 1-1.5 m/min and the fiber diameter to 170-220 m. The kinetics of drug release could 
be adjusted by varying the GS loading of the fibers and the suspension preparation conditions. 
Gradual release of 80% of the initial GS content was measured in phosphate buffered saline 
at 37°C over 50 days from fibers spun from nonhomogenized suspensions, whereas loss of this 
amount of antibiotic occurred in less than 10 days from fibers spun from homogenized 
suspensions. Studies of growth inhibition of Stapyhlococcus epidermidis in culture indicated that 
GS released after 2 weeks from PCL fibers retained antibacterial activity. This behavior 
recommends further investigation of PCL fibers for local delivery of antibiotics to combat 
infection associated with periodontal disease, musculoskeletal injuries, and implantation of fiber-
based tissue substitutes such as vascular prostheses. © 2007 Wiley Periodicals, Inc. J Biomed 
Mater Res, 2007 
INTRODUCTION 
Infection following musculoskeletal injuries and surgical implantation is generally treated by
debridement and irrigation and systemic antibiotic therapy. Continuous antibiotic irrigation can be
prolonged in some cases over time periods approaching 1 month, and systemic antibiotic therapy
may be ineffective for treatment of musculoskeletal infection where the blood supply is often 
compromised. Systemic administration can also pose problems of toxicity to bystander
tissues.[1][2] Controlled delivery of antibiotics from a variety of polymeric and inorganic 
vehicles[3-7] has therefore been widely investigated with the aim of maintaining high, nontoxic, 
and local concentrations without producing adverse systemic effects. Natural and synthetic
polymer fibers are used extensively for soft tissue repair in the form of sutures, vascular grafts,
and meshes.[8-10] However, textile vascular prostheses and the sewing rings of artificial heart
valves manufactured from Dacron polyester fibers provide a possible source of infection once
implanted. This complication is difficult to treat by systemic delivery of antibiotics and can
necessitate removal of the prosthesis or lead to postoperative morbidity. Infection of Dacron is
commonly caused by staphylococci, gram negative cocci, or mixed organisms and is responsive to
broad spectrum antibiotics (covering Stapyhlococcus aureus and Stapyhlococcus epidermidis) 
therefore been investigated to supplement the local concentration levels achieved by systemic 
drug administration. Coating of knitted Dacron material with gentamicin derivatives in a carrier of
fibrin sealant resulted in continuous drug release for 3 weeks (after peaking at day 3) and
inhibition of Bacillus subtilis growth in culture.[3] Immersion of gelatin-sealed Dacron vascular 
grafts in rifampin solution prior to implantation has also been used to prevent infection by S. 
aureus and S. epidermidis.[11] 
The production of antibiotic-loaded fibers offers advantages over coated fibers and textiles
because of the possibility of improving drug distribution and the potential for controlling release
kinetics. Antibiotic-loaded alginate fibers intended for burn treatments have been wet spun from 
sodium alginate solutions containing dispersed silver sulphadiazine powder.[12] Melt spinning of 
tetracycline-loaded fibers from synthetic polymer/drug mixtures for periodontal disease therapy
enabled variation of antibiotic release rates through polymer selection.[13] Polycaprolactone 
(PCL) fibers, for example, released the total tetracycline load (25% w/w) in 1 day in vitro, 
whereas poly(ethylene vinyl acetate) [PEVA] fibers sustained release for up to 9 days. The initial
burst release phase exhibited by the PEVA system resulted in high antibiotic concentrations of
500 g/mL initially within periodontal pockets, and the levels could be maintained at 50 
g/mL by weekly replacement of the fibers. Discontinuous PEVA and PLA fibers containing
tetracycline compounds have been electrospun from solutions of the drug and polymer in
chloroform/methanol mixtures.[14] Approximately 65% of the drug content was gradually
released from PEVA fiber mats over 5 days in vitro, whereas instantaneous burst release of around 
30% of the drug load occurred from PLA fiber mats over the same timescale. 
Gravity-spun PCL fibers have recently been developed for applications in soft tissue
engineering.[15][16] They exhibit high compliance and extensibility and can be loaded with
proteins or hydrophobic steroids by fiber spinning from particulate dispersions or cosolutions of
the drug and polymer, respectively. The fibers also provide a favorable substrate for growth of a 
variety of cell types in culture. Here we report on the incorporation of gentamicin sulphate (GS) in
gravity-spun PCL fibers to illustrate the potential for controlled, local delivery of antibiotics from
wound closure materials, and tissue substitutes such as textile vascular grafts. 
MATERIALS AND METHODS 
PCL (CAPA 650, Mw 115,000) was obtained from Solvay Interox, Warrington UK. GS, o-
phthaldialdehyde (OPA) reagent, and phosphate buffered saline (PBS) were purchased from
Sigma Chemicals, Australia. Nutrient broth was prepared from 25 g nutrient stand (AM132, Amyl
Meida Pty Ltd., Australia) in 1 L deionized water. Nutrient agar (1.5%) was made from 15 g agar
(Ajax Finechem, Australia) in 1 L nutrient broth. S. epidermidis were supplied by Ms. Helen 
Agus, School of Molecular and Microbial Biosciences, University of Sydney. 
Production of GS-loaded PCL fibers 
Fibers were produced using the gravity spinning method.[15] PCL was dissolved in acetone with 
gentle heating to produce a 20% w/v solution and GS powder was added to form a 5, 10, and 20%
w/w dispersion, respectively. The GS-PCL suspension was homogenized using a Silverson
homogenizer (Silverson Machines, Chesham, Bucks, UK) at 5600 rpm for 40 s before transfer to
the reservoir of a glass spinneret, the free end of the capillary (1 mm internal diameter) being
positioned below the surface of methanol in a nonsolvent bath. Suspensions (20% w/w) of GS in
20% w/v PCL solution were also produced by simple mixing without a homogenization stage.
Each suspension was subsequently allowed to flow under gravity through the spinneret into the 
nonsolvent bath. 
The morphology of GS-loaded PCL fibers 
GS-loaded PCL fibers and drug-free PCL fibers were attached to aluminum SEM stubs using
carbon tabs and sputter coated with platinum using a Metaserv automatic mounting press. The
morphology and surface topography of the fibers were examined using a Philips scanning electron
microscope (SEM 505) at an operating voltage of 15kV. Samples of GS-loaded fibers were also 
dissolved in dichloromethane (DCM) and the resulting suspension was dropped onto SEM stubs.
Specimens were examined by SEM after solvent evaporation to provide information on the
particle size of the GS powder phase following fiber spinning. 
Tensile properties of GS-loaded PCL fibers 
The tensile properties of as-spun PCL fibers and GS-loaded fibers were measured at room 
temperature using an Instron 5567 tensile testing machine at a crosshead speed of 15 mm/min.
Specimens with gauge length of 25 mm were tested in triplicate and the fiber extension was
approximated from the crosshead movement. Fiber tensile modulus (or Young modulus, E), 
tensile strength, and percent failure extension were determined. Fiber diameters were measured
using an Olympus CH40 optical microscope having a calibrated eyepiece graticule. The fiber
diameter was also measured before and after immersion of samples in PBS at 37°C for 30 days. 
Thermal behavior 
The thermal behavior of GS-loaded PCL fibers and drug-free fibers was investigated using a TA 
Instruments differential scanning calorimeter 2920. Samples were sealed in aluminum pans and
heated from room temperature to 80°C at a rate of 10°C/min. The percentage crystallinity was
estimated using a value of 139.5 J/g for the heat of fusion of fully crystalline PCL.[17] 
Measurement of GS loading of PCL fibers 
Samples of GS-loaded fibers ( 30 mg, accurately weighed) were dissolved in 1 mL DCM and
9 mL water was added to precipitate the PCL polymer. The sample tube was shaken for 24 h (IKA 
Vibrax VXR) to obtain a thorough mixing of DCM and water and to evaporate the organic
solvent. The GS content of the fibers partitioned into the water phase. The aqueous solution
obtained for each sample was collected and retained at 4°C prior to quantitative analysis of the GS
concentration using the OPA assay.[18] The homologous aromatic dialdehyde, OPA is essentially
nonfluorescent until it reacts with a primary amine in the presence of excess sulfhydryl such as 2-
mercaptoethanol to yield a fluorescent isoindole. An aliquot (1 mL) of the aqueous solution 
containing GS was added to 1 mL isopropanol and 1 mL OPA reagent. The samples were retained
at room temperature for 45 min before measuring the UV absorbance at 333 nm using a U-2000 
spectrophotometer (Hitachi, Tokyo, Japan). The GS concentration was obtained by comparison 
with a calibration curve produced using a series dilution of GS in water (15-120 g/mL). 
In vitro release of GS from PCL fibers 
Three samples of GS-loaded PCL fibers (30 mg) were weighed and each sample was immersed in
2.5 mL PBS at 37°C. The complete release media were collected at various time periods over 50
days and stored at 4°C prior to testing for GS content by OPA analysis. Fresh buffer was added to 
calculated in terms of cumulative (%) and weight of GS released per milligram of fibers and
plotted versus time. 
Bacteria growth inhibition by GS released from PCL fibers 
S. epidermidis was incubated in sterile nutrient broth at 37°C for 48 h. The broth (1 mL) was
transferred into nutrient agar tubes (15 mL) and each tube was gently rolled to ensure thorough
mixing. The agar contents of each tube were poured aseptically into sterile Petri dishes and
allowed to set. Samples (30 mg) of GS-loaded fibers (spun from nonhomogenized suspensions)
that had been retained in PBS release medium (2.5 mL) at 37°C for 1, 7, and 14 days respectively 
were embedded in the centre of agar plates to provide triplicate measurements at each release
period. Drug-free PCL fibers were used as controls. The antibacterial activity of GS-loaded fibers 
was assessed after 24 h incubation at 37°C by measuring the mean diameter of the zone of 
inhibition (ZoI) to the nearest millimeter. 
RESULTS 
GS is insoluble in most organic liquids (including acetone and methanol) but freely soluble in
water (>1 g/mL) and was therefore incorporated in PCL fibers by spinning from suspensions of 
GS powder in a high concentration (20% w/v) polymer solution. Attempts to produce GS-loaded 
fibers using lower concentration solutions were unsuccessful. The use of homogenized dispersions
had little effect on the fiber production rate compared with spinning of drug-free fibers whereas 
the rate was decreased to 1 m/min when nonhomogenized dispersions were used (Table I). The 
starting GS powder comprised spherical particles ranging in size from 5-25 m (Fig. 1). 
However, when GS-loaded fibers produced from homogenized suspensions were dissolved in 
DCM and analyzed by SEM, only isolated 2-3 m diameter microspheres were observed on a 
background polymer film. Microspheres of 5-15 m were visible in the case of fibers prepared 
from nonhomogenized suspensions. Thus the spinning behavior of homogenized suspensions 
probably reflects the unrestricted flow pattern of smaller GS particulates through the spinneret
capillary. The diameter of GS-loaded fibers produced from homogenized suspensions increased
by a maximum of 18% relative to drug-free fibers with no significant correlation with GS loading 
(Table I). In contrast, GS-loaded fibers prepared from nonhomogenized suspensions displayed 
major increases in diameter (50%) reflecting the larger size of incorporated particles. The fiber
diameter for both spinning conditions remained unchanged after immersion of samples in PBS at
37°C for 30 days.  
  
 
Figure 1. Gentamicin sulphate microspheres 
 
  
Table I. Processing and Thermal Properties of Gentamicin Sulphate-
Loaded PCL Fibers 
 
PCL 
Conc. in 
Spinning 
Solution 
(% w/v) 
Gentamicin 
Sulphate 
Loading of 
Spinning 
Solution 
(% w/w) 
Fiber 
Production 
Rate 
(m/min) 
Gentamicin 
Sulphate 
Loading of 
Fiber (% 
w/w) 
Fiber 
Diameter 
( m) 
Tm 
(°C)
Crystallinity 
(%) 
 
20 - 1.4 - 149 ± 16 60.6 62.4 ± 2.8 
20a 5 1.5 5.0 ± 1.0 169 ± 17 62.1 60.9 ± 4.0 
20a 10 1.4 9.0 ± 0.8 172 ± 23 60.2 55.3 ± 7.6 
20a 20 1.5 18.5 ± 1.2 176 ± 13 60.4 59.9 ± 4.4 
20b 10 1.0 6.4 ± 0.7 221 ± 31 62.7 63.7 ± 2.8  
 
   Gentamicin sulphate dispersed in PCL solution by homogenizationa or simple mixingb. 
Drug-free PCL fibers and GS-loaded fibers exhibit a similar roughened surface texture. The
morphology of GS-loaded fibers prepared from homogenized suspensions is characterized by 
numerous pores on the 1-5 m scale together with surface fissures and is unaffected by
immersion in PBS at 37°C for time periods up to 25 days (Fig. 2). The undulating, rippled surface 
texture of GS-loaded PCL fibers prepared from nonhomogenized suspensions is shown in Figure
3. The fibers appeared more pitted and dimpled after 30 days immersion in PBS at 37°C, possibly
because of the loss of antibiotic exposed at the fiber surface. Microspheres of GS were not evident
in both types of fiber, indicating the influence of various factors such as efficient particle coverage 
or embedding in the polymer phase and particle size reduction during suspension preparation and
fiber production. 
   
 
Figure 2. The surface morphology of 18.5% GS-loaded PCL fibers spun 
from homogenized suspensions: (a) as-spun fibers, (b) after immersion for 
25 days in PBS at 37°C. 
 
 
 
 
Figure 3. The surface morphology of 6.4% GS-loaded PCL fibers 
spun from nonhomogenized suspensions: (a) and (b) as-spun fibers, 
(c) after immersion for 30 days in PBS at 37°C. 
 
Gentamicin loading of fibers 
The GS loading of the various PCL fiber formulations investigated is shown in Table I. The use of 
homogenized suspensions resulted in high loading efficiencies in excess of 90%, whereas simple
mixing of GS in the PCL solution resulted in a reduced loading efficiency of 64%. An almost
linear relationship between GS loading of the fiber and the spinning solution was observed in the
thus improving antibiotic dispersion in the PCL solution and consequently in the fiber. 
Fiber thermal characteristics and tensile properties 
The thermal characteristics of drug-free fibers and GS-loaded fibers are shown in Table I. The 
melting points of PCL fibers and GS-loaded fibers were similar to the generally reported values
for PCL (58-61°C) and were unaffected by GS loading. Mean fiber crystallinity was generally
confined to the range 60-64%, although a lower crystallinity (55%) and broader range of
measurements were recorded for the PCL phase in 9% GS-loaded fibers. 
Drug-free PCL fibers produced from 20% w/v solutions were found to exhibit a tensile modulus
(E) of 0.04 GPa, tensile strength of 7.7 MPa, and failure extension of 850% (Table II). GS-
loaded PCL fibers spun from homogenized suspensions exhibited consistently lower tensile 
strength and elongation compared with drug-free fibers. GS-loaded PCL fibers (6.4% w/w) 
produced from nonhomogenized suspensions exhibited a 30% increase in modulus and similar
tensile strength compared with drug-free fibers.  
  
Table II. Tensile Properties of Gentamicin 
Sulphate-Loaded PCL Fibers 
 
Gentamicin 
Sulphate 
Loading of 
Fibres (% w/w)
Tensile 
Modulus 
(GPa) 
Tensile 
Strength 
(MPa) 
% Failure 
Extension 
- 0.04 ± 
0.01 
7.7 ± 1.4 847.4 ± 
39.8 
5.0a 0.04 ± 
0.02 
5.4 ± 0.9 314.0 ± 
31.7 
9.0a 0.03 ± 
0.01 
4.2 ± 1.0 356.5 ± 
151.7 
18.5a 0.05 ± 
0.02 
5.4 ± 1.9 249.1 ± 
81.5 
6.4b 0.06 ± 
0.02 
7.4 ± 2.0 537.6 ± 
42.6  
 
   Gentamicin sulphate dispersed in PCL solution by 
homogenizationa or simple mixingb. 
 
In vitro release of GS from PCL fibers 
The effect of spinning conditions and drug loading on the in vitro release behavior of GS from 
PCL fibers is illustrated in Figure 4. A burst effect was generally observed in the first 4 h, with
magnitude increasing with drug loading [Fig. 4(a)]. A greater burst effect was observed for fibers 
spun from homogenized suspensions relative to nonhomogenized suspensions. Around 80 and
50%, respectively, of the initial drug content was lost from the highest loading fibers (18.5% w/w)
and lowest loading fibers (5% w/w) in the first 24 h. PCL fibers prepared using homogenized
suspensions released 80-90% of the initial GS load over 10 days in PBS at 37°C and the release
profile then plateaued [Fig. 4(b)]. In contrast, GS-loaded PCL fibers spun from nonhomogenized 
suspension exhibited a more gradual and sustained release behavior. The burst phase was limited
to 30% of the GS content at 24 h, whereas 60% of the antibiotic load had been delivered by 
10 days and 78% at 50 days [Fig. 4(b)].  
 
 
Figure 4. The release behavior of gentamicin sulphate from PCL fibers in 
PBS at 37°C (a) 24 h (cumulative %), (b) 50 days (cumulative %), and (c) 
amount per milligram fibers per day. (Fibers spun from nonhomogenized * 
and homogenized suspensions.) 
 
Antibacterial activity of GS-loaded PCL fibers 
The bacteria inhibition assay revealed clear zones of inhibition of S. epidermidis growth around 
GS-loaded PCL fibers that had been retained in PBS at 37°C for 1, 7, and 14 days respectively,
prior to testing. Clear zones were absent in control culture plates containing drug-free fibers (Fig. 
5). The results confirmed that GS is released with retained activity from PCL fibers over a 2-week 
timescale. The corresponding reduction in average zone diameter of 17% reflects the 
progressive decrease in the amount of antibiotic released over 14 days (Fig. 4). 
  
 
Figure 5. The relationship between the diameter of the zone of inhibition 
in S. epidermidis inoculated culture plates and the duration of antibiotic 
release from 6.4% GS-loaded PCL fibers. (Fibers produced from 
nonhomogenized suspensions.) 
 
DISCUSSION 
Successful production of GS-loaded PCL fibers from particulate dispersions relies on adequate
cohesion of the polymer solution stream in the nonsolvent bath and a viscosity sufficient to
maintain an even distribution of drug particles. The process of solvent extraction leads in turn to
coagulation of the solution thread, polymer precipitation and hardening of the fiber which
subsequently enables fiber collection on the take-up mandrel. In the present work, use of a high 
concentration PCL solution (20% w/v) was necessary to raise the viscosity of the carrier medium
and avoid phase separation of the dispersion under gravity flow conditions. Loss of drug particles
was not observed during fiber transit through the nonsolvent bath. The combination of effective 
particle entrapment, combined with the insolubility of GS in methanol, resulted in efficient drug
incorporation in the fiber particularly when homogenized dispersions were employed. The lower
antibiotic loading efficiency obtained for fibers spun from nonhomogenized dispersions suggests
that a fraction of the GS particles may be poorly dispersed and retained in the spinneret. 
GS-loaded fibers produced from homogenized suspensions exhibited a decrease in tensile strength
and extensibility compared with drug-free fibers (Table II). This behavior may be conveniently 
attributed to the decreased load bearing area of the fiber polymer phase and the stress raising
effects of GS particulates concentrated in the fiber surface region. The expected reduction in
fracture toughness of the fiber surface associated with the high particle loading would facilitate 
crack initiation and propagation. Support for this mechanism is provided by the pattern of
antibiotic release from the fibers. Rapid loss of around 80% of the antibiotic in 2 days from fibers
produced using homogenized dispersions indicates that most of the drug is located at or close to
the fiber surface. The lower strength of 9% GS-loaded fibers correlates with a corresponding 
decrease in sample crystallinity (Table I), which suggests a strong influence of the elastomeric
amorphous phase of PCL on the fiber mechanical properties. The reinforcing effect of inorganic
particulates such as talc and glass on thermoplastics is well known[19] and appears to be 
operational in the case of GS-loaded fibers prepared from nonhomogenized suspensions. The
increase in stiffness relative to drug-free fibers and those spun from homogenized suspensions
may reflect a more uniform distribution of particles and adhesive bonding between the PCL and 
GS phase which improves load transfer. 
The burst release characteristic exhibited by fibers produced using homogenized dispersions is
similar to that reported for tetracycline-loaded, melt-spun PCL fibers[13] and indicates that most 
of the drug is exposed at the fiber surface, possibly through pores and fissures (Fig. 3). The more 
gradual release behavior observed for fibers spun from nonhomogenized dispersions may be 
explained by protrusion of GS particles through the fiber surface which, on solubilization,
provides pathways for fluid ingress. A network of pores and channels within the fiber matrix, part
formed by contact between dispersed powder, may permit dissolution of more deeply embedded 
material.[20][21] 
Aminoglycoside antibiotics such as streptomycin and gentamicin exhibit bactericidal activity
against a broad range of microorganisms such as S. aureus and Enterobacteriaceae. They exhibit 
concentration dependent killing of bacteria, generally by penetrating the outer cell wall
and binding with the cytoplasmic membrane. The subsequent loss of permeability control for
small (K+) and large molecules (nucleotides, proteins e.g. -galactodase) creates the potential 
lethal event.[22] Staphylococci such as S. aureus and S. epidermidis are the most common 
pathogens associated with osteomyelitis and cardiovascular implant infection. GS-loaded PCL 
fibers, which had been retained in PBS for up to 14 days, maintained antibacterial activity against
gram positive S. epidermidis. The corresponding amounts of 150, 37, and 30 g of GS 
released from PCL fibers (30 mg) in PBS between day 1-2, 7-8, and 14-15, respectively [Fig. 
4(c)], is sufficient to inhibit growth of bacteria inoculated on agar plates. In comparison,
unspecified weights of Dacron vascular graft coated with gentamicin and fibrin sealant resulted in
rapid delivery of 225 g of antibiotic in PBS at 37°C at day 3, followed by gradually declining
levels of 100 and 50 g at day 7 and 14 respectively. This particular release profile was
sufficient to inhibit growth of B. subtilis in culture for 21 days.[3] 
In vitro release of GS from 6.4% loaded PCL fibers far exceeds the minimum inhibitory
concentration (MIC) of 4 g/mL relevant to gentamicin-sensitive bacteria.[2] However, 
extrapolation of in vitro, antibacterial performance to in vivo efficacy is complicated by drug 
clearance factors such as the extent of vascularization of local tissue and drug/tissue interactions.
Drug diffusion can be impeded by the presence of biofilms and necrotic tissue, for example, which
can severely limit the effectiveness of antibiotics.[4] Total and rapid release of gentamicin from 
collagen sponges have been reported in 60 min in vitro, leading to high local tissue concentrations 
(e.g. 2000 g/mL) within 24 h of implantation. However, antibiotic levels could be maintained
above the MIC for gentamicin-sensitive organisms for around 7 days[2] reflecting the tendency 
for the polar drug to be excluded from most cells and to accumulate in body tissues.[23][24] The 
initial burst release from implanted GS-loaded fibers could be useful for achieving local,
concentration-dependent killing of bacteria resulting from implant-related infection or poor 
surgical procedures. In addition, the sustained release characteristic may be advantageous for
elevating local antibiotic levels over a larger tissue volume for combating less virulent organisms 
such as S. epidermidis, which colonize grafts effectively but result in delayed clinical signs of
infection. 
The advantages of combining antibiotics such as minocycline and rifampin relate to the broader
spectrum of activity against gram positive and negative organisms and the avoidance of antibiotic
resistance because of the differing modes of action of the antibiotics.[11][25] Furthermore, 
vancomycin-sodium salicylate combinations have been shown to be more effective than the
individual components against S. epidermidis - containing biofilms[26] that present a significant 
obstacle to effective control of cardiovascular infections. Thus production of PCL fibers
containing combination antimicrobials would provide a logical extension of the work described 
here. Sterilization of PCL by -irradiation has been found to reduce the molecular weight by
up to 30% and the polymer tensile strength by 12%.[27] Similar effects are anticipated following 
-sterilization of PCL fibers, which may affect the antibiotic release kinetics. This aspect also
requires investigation to fully assess the clinical usefulness of antibiotic-loaded PCL fibers. 
CONCLUSIONS 
PCL fibers can be loaded with the antibiotic, GS, by gravity spinning from dispersions of drug
particles in PCL solution. The avoidance of high temperatures during fiber spinning is
advantageous for incorporating heat-labile antibiotics. Gradual release of 80% of the 
antibiotic load occurred from fibers produced from nonhomogenized suspensions over 50 days in 
PBS, and the GS released after 14 days inhibited growth of S. epidermidis in culture. Gravity 
spinning is potentially useful for production of PCL fibers, which provide controlled local
delivery of antibiotics for combating infection associated with musculoskeletal injuries, 
implantation of fiber-based tissue substitutes, and periodontal disease. 
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